1. Bone Sarcomas: From Biology to Targeted Therapies
   Nathalie Gaspar et al, 2012, Sarcoma CrossRef
2. Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells
   Tomohiro Fujiwara et al, 2016, Stem Cells International CrossRef
3. Discovery of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity
   Jinxin Che et al, 2021, Journal of Medicinal Chemistry CrossRef
4. Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
   AeRang Kim et al, 2020, Sarcoma CrossRef
5. Evolutionary and cellular analysis of the ‘dark’ pseudokinase PSKH2
   Dominic P. Byrne et al, 2023, Biochemical Journal CrossRef
6. Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells
   Xiaodong Mu et al, 2013, Sarcoma CrossRef
7. Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines
   Cecilia Garofalo et al, 2015, Frontiers in Endocrinology CrossRef